Please login to the form below

Not currently logged in
Email:
Password:

safinamide

This page shows the latest safinamide news and features for those working in and with pharma, biotech and healthcare.

FDA approves Newron's Parkinson's disease drug Xadago

FDA approves Newron's Parkinson's disease drug Xadago

Newron Pharmaceuticals’ Xadago (safinamide) was approved as an add-on treatment for patients already on levodopa/carbidopa and who experience ‘off’ episodes when those medications don’t work well.

Latest news

  • Newron back on track for Xadago approval in US Newron back on track for Xadago approval in US

    The Italian pharma company's partner Zambon is already rolling Xadago (safinamide) out in Europe following its EMA approval last year, and has just launched in Norway taking the tally of ... We assume the safinamide label could be expanded to include

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015’

    neprilysin inhibitor. Novartis. USA. safinamide. Xadago. Parkinson's disease. MAO-B inhibitor. Newron Pharma.

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    Currently available therapies of this class include selegiline and rasagiline. Safinamide (Newron, Zambon and Meiji Seika Pharma) is a selective and reversible MAO B inhibitor in the absence of MAO-A

  • Oncology bias in pharma deals

    Merck Serono's decision to return the rights to Safinamide (an alpha aminoaminde in phase III, as an add-on therapy to dopamine agonists or levodopa for dyskinesia in Parkinson's ... Termination of acquisition. Safinamide (alpha aminoamide) adjunct

  • Next generation

    Safinamide (Merck Serono) is an MAOB inhibitor currently in phase III trials as an adjunctive therapy for the treatment of PD. ... However, safinamide also acts as a glutamate release inhibitor, as well as a sodium and calcium channel blocker.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...